跳至主要内容
临床试验/JPRN-UMIN000010324
JPRN-UMIN000010324已完成未知

Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer - CBDCA/ weekly nab-PTX for elderly NSCLC patients

orth Japan Lung Cancer Study Group0 个研究点目标入组 35 人开始时间: 2013年3月27日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
75years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Previous treatment with paclitaxel as adjuvant chemotherapy 2) Active double cancer 3) Symptomatic brain metastasis 4) Pleural and peritoneal effusion likely to require surgical intervention, or pericardial effusion 5) Grade 2 or higher peripheral neuropathy 6) Radiographically confirmed interstitial pneumonitis or pulmonary fibrosis 7) Severe concurrent disease (Ischemic heart disease requiring treatment, arrhythmia, cardiac infarction within 6 months before enrollment, hepatic failure, hemorrhagic peptic ulcer, poorly controlled diabetes) 8) History of Severe drug allergies. 9) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy. 10) Physician concludes that the patient's participation in this trial is inappropriate.

研究者

发起方
orth Japan Lung Cancer Study Group

相似试验

Phase II study of Carboplatin plus weekly... | 临床试验